Fig. 4From: Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysisForest plots of the correlation between nestin expression and IHC markers. a ER (positive vs. negative); b PR (positive vs. negative); c HER2 (positive vs. negative); d Ki-67 (high vs. low); e TNBC vs. Non-TNBC; f CK5 (positive vs. negative); g P-cadherin (positive vs. negative); h EGFR (positive vs. negative); i BLP1 (present vs. absent); j BLP2 (present vs. absent); k BLP3 (present vs. absent); l BLP4 (present vs. absent); m BLP5 (present vs. absent); n p53 (positive vs. negative); o FOXA1 (positive vs. negative)Back to article page